| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00061 | 1 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.00099 | 1 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.00035 | 1 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -4.6e-05 | 1 |